Gout earned its reputation as a “rich man’s disease” because the foods and drinks that trigger it were, for most of human history, luxuries only the wealthy could regularly afford. Red meat, organ meats, shellfish, wine, and sugar-sweetened delicacies all raise levels of uric acid in the blood, and for centuries these sat on aristocratic tables far more often than on peasant ones. The label stuck so thoroughly that it shaped how doctors and the public think about gout to this day, but modern evidence tells a more complicated and, in some ways, opposite story.
How the Nickname Took Root
The association between gout and privilege is ancient. Greek and Roman physicians noticed that gout disproportionately struck the elite. One reason may have been uniquely grim: Roman aristocrats drank wine stored in lead-lined vessels and cooked with lead-containing sweeteners, and lead poisoning impairs the kidneys’ ability to clear uric acid. Researchers have argued that this “saturnine gout” was widespread among the Roman upper class, and that the resulting epidemic of kidney damage and joint disease may have contributed to broader health decline in the ruling elite.1PubMed. Saturnine gout among Roman aristocrats. Did lead poisoning contribute to the fall of the Empire?
Through the medieval and early modern periods, the pattern continued. Gout appeared frequently in royal courts and among the merchant class. Henry VIII, Benjamin Franklin, and Charles Darwin all famously suffered from it. The condition became almost a badge of status, proof that one could afford to overindulge. Medical writers of the 18th and 19th centuries reinforced this by recommending that gout patients cut back on port wine, rich sauces, and game meats. Archaeological evidence from medieval Cambridge has shown crystal deposits consistent with gout in skeletal remains, offering physical confirmation that the disease was present in these historical populations.2PubMed Central. Gout and ‘Podagra’ in medieval Cambridge, England
The Dietary Triggers That Built the Myth
The connection between diet and gout is real, which is part of why the “rich man’s disease” label has been so persistent. When your body breaks down compounds called purines, the end product is uric acid. Humans, unlike most other mammals, cannot break uric acid down further because we lack a functional version of the enzyme that would convert it into a more easily excreted substance.3PubMed. Regulation of uric acid metabolism and excretion So uric acid accumulates in our blood, and when levels climb high enough, it can crystallize in joints and trigger the intense inflammatory attacks that define gout.
Certain foods are particularly good at pushing uric acid levels up. A large prospective study of men found that those who ate the most meat had roughly 40 percent higher risk of developing gout compared to those who ate the least, and the highest seafood consumers had about 50 percent greater risk.4PubMed. Purine-rich foods, dairy and protein intake, and the risk of gout in men A meta-analysis pooling multiple studies confirmed the pattern and extended it: red meat, seafood, alcohol, and fructose all raised risk, while dairy products and soy foods were associated with lower risk.5PubMed. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review
For most of recorded history, regularly eating red meat, shellfish, and rich alcohol was a marker of wealth. Peasants and laborers ate grains, root vegetables, and whatever cheap protein they could get, which happened to be a relatively low-purine diet. The wealthy ate venison, organ meats, sardines, and anchovies, washed down with wine or beer. The dietary triggers for gout mapped almost perfectly onto the foods of affluence, and the disease followed. The nickname wrote itself.
Why the Nickname Is Wrong Today
The economics of food changed dramatically over the past century. Processed meat, sugary soft drinks, and beer are now among the cheapest calories available in industrialized countries. A fast-food hamburger costs less than a salad. High-fructose corn syrup is in everything from bread to condiments. The dietary risk factors for gout are no longer luxuries; in many places, they are the default diet for people with limited incomes.
Epidemiological data reflects this shift. A cross-sectional study of primary-care patients in the United Kingdom found that, after adjusting for other factors, inadequacy of income was significantly associated with gout, with people reporting insufficient income having roughly 44 percent higher odds of having the disease.6PubMed Central. The association of gout with socioeconomic status in primary care: a cross-sectional observational study That finding runs directly counter to the old stereotype. Gout today is more common in populations dealing with obesity, metabolic syndrome, hypertension, and kidney disease, conditions that cluster in lower-income communities with less access to healthcare and fresh food.
The prevalence of gout has also risen sharply worldwide over recent decades, driven by population-level increases in obesity and metabolic disease. This is not a trend confined to the wealthy. In many countries, gout rates are climbing fastest in communities with the highest rates of food insecurity, where calorie-dense but nutrient-poor diets are the norm.
Genetics Play a Bigger Role Than Most People Realize
One of the most persistent misconceptions about gout is that it is primarily a lifestyle disease, something you bring on yourself through overindulgence. The reality is that genetics account for a large share of the variation in blood uric acid levels, and inherited differences in how the kidneys handle uric acid matter at least as much as what you eat.
Several genes control uric acid transport in the kidneys and gut. Variations in a gene called ABCG2, which encodes a protein that pumps uric acid out of cells and into the intestine for excretion, have been strongly linked to gout risk. In a Korean study, patients with gout were far more likely to carry certain variants of ABCG2 and another transporter gene called SLC2A9 than healthy controls, with the risk allele of ABCG2 roughly tripling the odds of gout.7PubMed Central. Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population These genetic variants do not care about your income, your diet, or your social class. They are distributed across populations in ways that have nothing to do with wealth.
This genetic dimension helps explain why some people eat purine-rich diets their entire lives and never develop gout, while others develop it despite fairly moderate diets. The “rich man’s disease” framing implies personal responsibility in a way that distorts the biology. Diet is one input, but the machinery that determines whether your body can clear uric acid efficiently is largely inherited.
Why Humans Are Uniquely Vulnerable to Gout
Gout is overwhelmingly a human problem, and the reason is evolutionary. Most mammals produce an enzyme called uricase that breaks uric acid down into a more soluble compound that the kidneys easily flush away. Humans and other great apes lost functional copies of this enzyme millions of years ago through a series of independent mutations.8PubMed Central. Evolutionary history and metabolic insights of ancient mammalian uricases Without uricase, our baseline uric acid levels are several times higher than those of most other mammals, putting us much closer to the crystallization threshold at all times.9PubMed Central. The Role of Uric Acid in Human Health: Insights from the Uricase Gene
Why evolution would have tolerated this seems counterintuitive, since gout is painful and debilitating. One hypothesis is that uric acid is a potent antioxidant in the blood, and higher levels may have conferred survival advantages at a time when our ancestors’ diets were low in vitamin C and other antioxidants.10PubMed. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity The change in uric acid handling also appears to have involved coordinated shifts in how the kidneys reabsorb uric acid. The transporter protein URAT1, which pulls uric acid back from the urine into the blood, evolved increased activity around the same time uricase was being lost, an event estimated to have occurred somewhere between 27 and 77 million years ago.11PubMed Central. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
The practical upshot is that every human walks around with uric acid levels that would be considered abnormally high in a dog or a cat. We are all, rich or poor, operating near the edge. It does not take much of a nudge from diet, genetics, kidney function, or medications like diuretics to push someone over the crystallization threshold.
What Actually Happens During a Gout Attack
When uric acid crystallizes in a joint, the immune system treats the crystals as a threat. The body activates an inflammatory cascade centered on a protein complex called the NLRP3 inflammasome, which triggers the release of powerful inflammatory signals.12PubMed Central. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout The result is the sudden, excruciating swelling that gout patients know all too well, often in the big toe, a location that has puzzled people for centuries.
The big toe is a prime target because several factors converge there. Uric acid is less soluble at lower temperatures, lower pH, and under physical stress, and the foot checks every box. The big toe joint is the coolest spot in the body, it bears enormous mechanical load during walking, and it sits at the extreme end of circulation. These conditions make it the ideal place for crystals to form and deposit.13PubMed Central. Revisiting the pathogenesis of podagra: why does gout target the foot?
The classical name for gout in the big toe, “podagra,” has been used since antiquity and remains the most recognizable presentation of the disease. But gout can strike ankles, knees, wrists, and fingers as well, especially in people who have had the disease for years.
Why Gout Attacks Hit at Night
If you have spoken to someone who has experienced gout, they probably told you the attack woke them up. There is a biological reason for this. Body temperature drops to its lowest point between about 2 and 6 in the morning, reaching around 36.4°C compared to roughly 37.5°C during daytime hours. Since uric acid becomes less soluble at lower temperatures, those early-morning hours create favorable conditions for crystal formation. On top of that, cortisol, the body’s natural anti-inflammatory hormone, bottoms out around midnight to 4 a.m., and mild dehydration during sleep may concentrate uric acid in the blood and joints.14PubMed Central. Nocturnal Risk of Gout Attacks
More recent research has also pointed to circadian variation in uric acid levels themselves, suggesting that the diurnal fluctuation in blood uric acid may directly influence when flares occur.15PubMed Central. Exploring the Impact of the Gut Microbiota/REV-ERBα/NF-κB Axis on the Circadian Rhythmicity of Gout Flares from a Chronobiological Perspective None of this has anything to do with what you ate for dinner, exactly. The timing of attacks is driven by your body’s own rhythms, not by the indulgence of a recent meal, which further undercuts the moralistic framing of gout as a consequence of gluttony.
The Stigma Problem
The “rich man’s disease” label does real harm. Because gout is culturally understood as self-inflicted, patients frequently feel ashamed of their diagnosis in ways that people with other forms of arthritis do not. Research on gout patients in New Zealand found that both internalized stigma (feeling personally ashamed) and anticipated stigma (expecting others to judge you) were common and were linked to worse pain, greater disability, and poorer adherence to medication.16PubMed Central. Internalized and Anticipated Stigmatization in Patients With Gout
This stigma feeds a vicious cycle. Patients who feel judged are less likely to take their urate-lowering medication consistently, which allows uric acid to stay elevated, which leads to more frequent attacks, which reinforces the sense that they must be doing something wrong. The “rich man’s disease” mythology also makes some clinicians less sympathetic; gout is sometimes treated dismissively in medical settings compared to conditions perceived as being out of the patient’s control. Younger patients and those from minority ethnic groups appear to experience higher levels of gout-related stigma.
Gout’s Links to Other Diseases
Elevated uric acid is not just a gout problem. It increasingly appears to be an independent risk factor for a constellation of other conditions, including high blood pressure, metabolic syndrome, kidney disease, and cardiovascular events.17PubMed Central. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? For decades, the medical community assumed that elevated uric acid was simply an innocent bystander, a byproduct of the same metabolic problems that caused these diseases. More recent evidence suggests the relationship may be causal in at least some cases, with uric acid itself contributing to blood vessel damage and kidney injury.
This matters for the “rich man’s disease” conversation because it means gout is not just a painful nuisance for people who eat too much steak. It is a marker of, and possibly a contributor to, serious systemic illness. Treating it as a joke about overindulgence means missing an opportunity to address cardiovascular and metabolic risk in the millions of people who develop it.
Why Men Get Gout Far More Often Than Women
Gout is roughly three to four times more common in men than in women, and the reason is primarily hormonal. Estrogen promotes uric acid excretion through the kidneys, which keeps blood levels lower in premenopausal women. After menopause, that protection fades, and gout rates in women climb substantially. A large population-based study of over a million postmenopausal women in South Korea found that earlier menopause was associated with higher gout risk, while later menopause was linked to lower risk.18PubMed Central. Association between female reproductive factors and gout: a nationwide population-based cohort study of 1 million postmenopausal women
This sex difference also contributed to the historical perception of gout as a man’s disease. In an era when medical writing was overwhelmingly produced by men, a condition that predominantly affected men and was associated with lavish dining naturally became coded as masculine excess. Women who developed gout, typically after menopause, were often overlooked or misdiagnosed. Even today, gout in women tends to be diagnosed later and treated less aggressively, in part because clinicians are slower to suspect it in a patient who does not match the stereotypical profile.
The Gut’s Overlooked Role
Most discussion of uric acid focuses on the kidneys, which handle about two-thirds of uric acid excretion. But the remaining third is excreted through the intestine, and emerging research suggests that gut bacteria play a meaningful role in that process. Changes in the composition and metabolism of the gut microbiota have been linked to abnormal uric acid handling, increased uric acid production, and the release of inflammatory mediators that can worsen gout.19PubMed Central. The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
Researchers are investigating whether modifying the gut microbiome could become a complementary approach to gout treatment. Animal studies have shown that certain compounds can increase the expression of urate transporters in the intestine and improve gut barrier integrity, effects that were accompanied by shifts in microbial composition and reduced uric acid levels.20PubMed Central. 6’‑O‑Caffeoylarbutin attenuates experimental hyperuricemia by regulating renal and intestinal urate transport, intestinal barrier integrity, and gut microbiota This line of research is still early, but it reinforces the point that gout is a systemic metabolic condition, not simply a punishment for eating the wrong foods.
An Ancient Treatment for an Ancient Disease
Colchicine, the drug most closely associated with acute gout treatment, has been used for over a thousand years.21PubMed Central. Colchicine: an ancient drug with novel applications It is derived from the autumn crocus, and its use for joint inflammation predates any modern understanding of uric acid or crystal formation. The drug works by disrupting the inflammatory cells that respond to urate crystals, essentially calming the immune overreaction rather than addressing the underlying uric acid problem.
Modern gout management has moved well beyond just treating attacks. Urate-lowering therapies like allopurinol and febuxostat work by reducing uric acid production, while newer drugs target the kidney transporters that reabsorb uric acid. The goal of long-term treatment is to keep blood uric acid below the level at which crystals form, dissolving existing deposits over time. Yet gout remains undertreated relative to its prevalence, in part because the “rich man’s disease” framing encourages both patients and doctors to view dietary changes as sufficient, when most patients with established gout need pharmacological treatment to achieve target uric acid levels. The persistence of a centuries-old nickname continues to shape clinical decisions in ways that do patients no favors.